Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Data on cancer vaccines detailed by researchers at INSERM
July 16th, 2008
New research, 'Delivery of mengovirus-derived RNA replicons into tumoural liver enhances the anti-tumour efficacy of a peripheral peptide-based vaccine,' is the subject of a report. According to recent research from Paris, France, "Hepatocellular carcinoma is a deadly cancer with growing incidence for which immunotherapy is one of the most promising therapeutic approach. Peptide-based vaccines designed to induce strong, sustained CD8+ T cell responses are effective in animal models and cancer patients." "We demonstrated the efficacy of curative peptide-based immunisation against a unique epitope of SV40 tumor antigen, through the induction of a strong CD8+ T...
Source: Vaccine Weekly (2008-07-16)
|
